Gene: SLC10A7
Official Full Name: solute carrier family 10 member 7provided by HGNC
Gene Summary: Predicted to enable symporter activity. Involved in bone development; heparin biosynthetic process; and intracellular calcium ion homeostasis. Located in Golgi apparatus; endoplasmic reticulum; and plasma membrane. [provided by Alliance of Genome Resources, Apr 2025]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO25238 | SLC10A7 Knockout cell line (HeLa) | Human | SLC10A7 | 1:3~1:6 | Negative | Online Inquiry |
KO25239 | SLC10A7 Knockout cell line (HCT 116) | Human | SLC10A7 | 1:2~1:4 | Negative | Online Inquiry |
KO25240 | SLC10A7 Knockout cell line (HEK293) | Human | SLC10A7 | 1:3~1:6 | Negative | Online Inquiry |
KO25241 | SLC10A7 Knockout cell line (A549) | Human | SLC10A7 | 1:3~1:4 | Negative | Online Inquiry |
SLC10A7 Gene Knockout Cell Lines are genetically engineered cellular models designed to lack the SLC10A7 gene, which encodes a solute carrier protein implicated in various biological processes. By utilizing CRISPR-Cas9 gene-editing technology, these cell lines enable researchers to study the physiological and pathological roles of SLC10A7 in cellular function, including its impact on ion transport, nutrient absorption, and cellular signaling pathways. This knockout allows for direct observation of the gene’s influence on various conditions, particularly those related to metabolic disorders and neurological functions.
The mechanisms underlying the utility of SLC10A7 knockout cell lines involve their ability to provide a controlled environment for dissecting the gene's role in both normal and diseased states. This tool becomes pivotal in elucidating the involvement of SLC10A7 in cellular mechanisms such as amino acid transport and potential contributions to diseases like diabetes and certain neurodegenerative conditions. Such insights can lead to novel therapeutic targets and biomarkers, accelerating advancements in precision medicine.
In research and clinical settings, the SLC10A7 knockout cell lines stand out due to their specificity and reproducibility. They offer clear genetic backgrounds that contrast with wild-type cells, enabling precise investigation of phenotypic changes resulting from the knockout. Unlike traditional methodologies that may involve complex gene manipulation, these knockout cell lines simplify the experimental design, saving researchers time and resources while increasing the reliability of their findings.
For researchers and clinicians, the value of SLC10A7 Gene Knockout Cell Lines lies in their potential to drive innovative research that furthers understanding of various diseases and informs the development of new therapeutic strategies. These cell lines represent an essential resource for those looking to explore gene function and its implications in health and disease.
Our company specializes in advanced genetic tools, ensuring that scientists have access to high-quality, reliable products that enhance their research capabilities and contribute to significant scientific discoveries.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.